Involvement of de novo synthesized palmitate and mitochondrial EGFR in EGF induced mitochondrial fusion of cancer cells

Cell Cycle

Volumn 13, Issue 15, 2014, Pages 2415-2430

  Bollu, Lakshmi Reddy ^a   Ren, Jiangong ^a   Blessing, Alicia Marie ^a   Katreddy, Rajasekhara Reddy ^a   Gao, Guang ^a   Xu, Lei ^a   Wang, Jinrong ^a   Su, Fei ^a   Zhang, Weihua ^a  

^a University of Houston   (United States)

Author keywords

Cancer; EGFR; Fatty acids synthase; Mitochondria; Mitochondrial fission; Mitochondrial fusion

Indexed keywords

6 [4 (4 ETHYL 1 PIPERAZINYLMETHYL)PHENYL] 4 (ALPHA METHYLBENZYLAMINO) 7H PYRROLO[2,3 D]PYRIMIDINE; ADENOSINE TRIPHOSPHATE CITRATE LYASE; CYSTEINE; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; FATTY ACID SYNTHASE; PALMITIC ACID; PROTEIN KINASE; FASN PROTEIN, HUMAN; MITOCHONDRIAL PROTEIN; PALMITIC ACID DERIVATIVE; PROTEIN KINASE INHIBITOR; PROTEIN TYROSINE KINASE;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL LINE; CELL FUSION; CELL ISOLATION; CELL MEMBRANE; CELL SURVIVAL; CONTROLLED STUDY; DRUG SENSITIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; MITOCHONDRION; MUTATIONAL ANALYSIS; PALMITOYLATION; PROSTATE CANCER; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; BREAST TUMOR; DRUG EFFECTS; DRUG RESISTANCE; FEMALE; MALE; METABOLISM; MITOCHONDRIAL DYNAMICS; PATHOLOGY; PROCEDURES; PROSTATE TUMOR; PROTEIN MICROARRAY; TUMOR CELL LINE;

BREAST NEOPLASMS; CELL LINE, TUMOR; CYSTEINE; DRUG RESISTANCE; EPIDERMAL GROWTH FACTOR; FATTY ACID SYNTHASE, TYPE I; FEMALE; HUMANS; MALE; MITOCHONDRIA; MITOCHONDRIAL DYNAMICS; MITOCHONDRIAL PROTEINS; PALMITATES; PROSTATIC NEOPLASMS; PROTEIN ARRAY ANALYSIS; PROTEIN KINASE INHIBITORS; PROTEIN-TYROSINE KINASES; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 84905905933     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.29338     Document Type: Article

References (60)

1. Flavin R, Peluso S, Nguyen PL, Loda M. Fatty acid synthase as a potential therapeutic target in cancer. Future Oncol 2010; 6:551-62; PMID:20373869; http://dx.doi.org/10.2217/fon.10.11
2. Kuhajda FP. Fatty-acid synthase and human cancer: new perspectives on its role in tumor biology. Nutrition 2000; 16:202-8; PMID:10705076; http://dx.doi.org/10.1016/S0899-9007(99)00266-X
3. Kuhajda FP, Jenner K, Wood FD, Hennigar RA, Jacobs LB, Dick JD, Pasternack GR. Fatty acid synthesis: a potential selective target for antineoplastic therapy. Proc Natl Acad Sci U S A 1994; 91:6379-83; PMID:8022791; http://dx.doi.org/10.1073/pnas.91.14.6379
4. Medes G, Thomas A, Weinhouse S. Metabolism of neoplastic tissue. IV. A study of lipid synthesis in neoplastic tissue slices in vitro. Cancer Res 1953; 13:27-9; PMID:13032945
5. Menendez JA, Lupu R. Oncogenic properties of the endogenous fatty acid metabolism: molecular pathology of fatty acid synthase in cancer cells. Curr Opin Clin Nutr Metab Care 2006; 9:346-57; PMID:16778562; http://dx.doi.org/10. 1097/01.mco.0000232893.21050.15
6. Pizer ES, Thupari J, Han WF, Pinn ML, Chrest FJ, Frehywot GL, Townsend CA, Kuhajda FP. Malonyl-coenzyme- A is a potential mediator of cytotoxicity induced by fatty-acid synthase inhibition in human breast cancer cells and xenografts. Cancer Res 2000; 60:213-8; PMID:10667561
7. Yarden Y, Pines G. The ERBB network: at last, cancer therapy meets systems biology. Nat Rev Cancer 2012; 12:553-63; PMID:22785351; http://dx.doi.org/10.1038/nrc3309
8. Asturias FJ, Chadick JZ, Cheung IK, Stark H, Witkowski A, Joshi AK, Smith S. Structure and molecular organization of mammalian fatty acid synthase. Nat Struct Mol Biol 2005; 12:225-32; PMID:15711565; http://dx.doi.org/10.1038/ nsmb899
9. Menendez JA, Lupu R. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer 2007; 7:763-77; PMID:17882277; http:// dx.doi.org/10.1038/nrc2222
10. Hynes NE, Lane HA. ERBB receptors and cancer: the complexity of targeted inhibitors. Nat Rev Cancer 2005; 5:341-54; PMID:15864276; http://dx.doi.org/10. 1038/nrc1609
11. Porstmann T, Griffiths B, Chung YL, Delpuech O, Griffiths JR, Downward J, Schulze A. PKB/Akt induces transcription of enzymes involved in cholesterol and fatty acid biosynthesis via activation of SREBP. Oncogene 2005; 24:6465-81; PMID:16007182
12. Van de Sande T, De Schrijver E, Heyns W, Verhoeven G, Swinnen JV. Role of the phosphatidylinositol 3′-kinase/PTEN/Akt kinase pathway in the overexpression of fatty acid synthase in LNCaP prostate cancer cells. Cancer Res 2002; 62:642-6; PMID:11830512
13. Yang YA, Han WF, Morin PJ, Chrest FJ, Pizer ES. Activation of fatty acid synthesis during neoplastic transformation: role of mitogen-activated protein kinase and phosphatidylinositol 3-kinase. Exp Cell Res 2002; 279:80-90; PMID:12213216; http://dx.doi.org/10.1006/excr.2002.5600
14. Menendez JA, Vellon L, Lupu R. Targeting fatty acid synthase-driven lipid rafts: a novel strategy to overcome trastuzumab resistance in breast cancer cells. Med Hypotheses 2005; 64:997-1001; PMID:15780499; http://dx.doi.org/10. 1016/j.mehy.2004.09.027
15. Poulsen Ll, Siersbæk M, Mandrup S. PPARs: fatty acid sensors controlling metabolism. Semin Cell Dev Biol 2012; 23:631-9; PMID:22273692; http://dx.doi.org/10.1016/j.semcdb.2012.01.003
16. Fiorentino M, Zadra G, Palescandolo E, Fedele G, Bailey D, Fiore C, Nguyen PL, Migita T, Zamponi R, Di Vizio D, et al. Overexpression of fatty acid synthase is associated with palmitoylation of Wnt1 and cytoplasmic stabilization of beta-catenin in prostate cancer. Lab Invest 2008; 88:1340-8; PMID:18838960; http://dx.doi.org/10.1038/labinvest.2008.97
17. Vazquez-Martin A, Colomer R, Brunet J, Lupu R, Menendez JA. Overexpression of fatty acid synthase gene activates HER1/HER2 tyrosine kinase receptors in human breast epithelial cells. Cell Prolif 2008; 41:59-85; PMID:18211286; http://dx.doi.org/10.1111/j.1365-2184.2007.00498.x
18. Jin Q, Yuan LX, Boulbes D, Baek JM, Wang YN, Gomez-Cabello D, Hawke DH, Yeung SC, Lee MH, Hortobagyi GN, et al. Fatty acid synthase phosphorylation: a novel therapeutic target in HER2-overexpressing breast cancer cells. Breast Cancer Res 2010; 12:R96; PMID:21080941; http://dx.doi.org/10.1186/bcr2777
19. Wang YN, Yamaguchi H, Hsu JM, Hung MC. Nuclear trafficking of the epidermal growth factor receptor family membrane proteins. Oncogene 2010; 29:3997-4006; PMID:20473332; http://dx.doi.org/10.1038/onc.2010.157
20. Xie Y, Hung MC. Nuclear localization of p185neu tyrosine kinase and its association with transcriptional transactivation. Biochem Biophys Res Commun 1994; 203:1589-98; PMID:7945309; http://dx.doi.org/10.1006/bbrc.1994.2368
21. Boerner JL, Demory ML, Silva C, Parsons SJ. Phosphorylation of Y845 on the epidermal growth factor receptor mediates binding to the mitochondrial protein cytochrome c oxidase subunit II. Mol Cell Biol 2004; 24:7059-71; PMID:15282306; http://dx.doi.org/10.1128/MCB.24.16.7059-7071.2004
22. Demory ML, Boerner JL, Davidson R, Faust W, Miyake T, Lee I, Hüttemann M, Douglas R, Haddad G, Parsons SJ. Epidermal growth factor receptor translocation to the mitochondria: regulation and effect. J Biol Chem 2009; 284:36592-604; PMID:19840943; http://dx.doi.org/10.1074/jbc.M109.000760
23. Yao Y, Wang G, Li Z, Yan B, Guo Y, Jiang X, Xi Z. Mitochondrially localized EGFR is independent of its endocytosis and associates with cell viability. Acta Biochim Biophys Sin (Shanghai) 2010; 42:763-70; PMID:20929928; http://dx.doi.org/10.1093/abbs/gmq090
24. Brand TM, Iida M, Li C, Wheeler DL. The nuclear epidermal growth factor receptor signaling network and its role in cancer. Discov Med 2011; 12:419-32; PMID:22127113
25. Yue X, Song W, Zhang W, Chen L, Xi Z, Xin Z, Jiang X. Mitochondrially localized EGFR is subjected to autophagic regulation and implicated in cell survival. Autophagy 2008; 4:641-9; PMID:18398293
26. Cvrljevic AN, Akhavan D, Wu M, Martinello P, Furnari FB, Johnston AJ, Guo D, Pike L, Cavenee WK, Scott AM, et al. Activation of Src induces mitochondrial localisation of de2-7EGFR (EGFRvIII) in glioma cells: implications for glucose metabolism. J Cell Sci 2011; 124:2938-50; PMID:21878501; http://dx.doi.org/10. 1242/jcs.083295
27. Westermann B. Mitochondrial fusion and fission in cell life and death. Nat Rev Mol Cell Biol 2010; 11:872-84; PMID:21102612; http://dx.doi.org/10.1038/ nrm3013
28. Lee YJ, Jeong SY, Karbowski M, Smith CL, Youle RJ. Roles of the mammalian mitochondrial fission and fusion mediators Fis1, Drp1, and Opa1 in apoptosis. Mol Biol Cell 2004; 15:5001-11; PMID:15356267; http://dx.doi.org/10.1091/mbc. E04-04-0294
29. Twig G, Elorza A, Molina AJ, Mohamed H, Wikstrom JD, Walzer G, Stiles L, Haigh SE, Katz S, Las G, et al. Fission and selective fusion govern mitochondrial segregation and elimination by autophagy. EMBO J 2008; 27:433-46; PMID:18200046; http://dx.doi.org/10.1038/sj.emboj.7601963
30. Gomes LC, Scorrano L. Mitochondrial elongation during autophagy: a stereotypical response to survive in difficult times. Autophagy 2011; 7:1251-3; PMID:21743300; http://dx.doi.org/10.4161/auto.7.10.16771
31. Cerveny KL, Tamura Y, Zhang Z, Jensen RE, Sesaki H. Regulation of mitochondrial fusion and division. Trends Cell Biol 2007; 17:563-9; PMID:17959383; http://dx.doi.org/10.1016/j.tcb.2007.08.006
32. Palorini R, De Rasmo D, Gaviraghi M, Sala Danna L, Signorile A, Cirulli C, Chiaradonna F, Alberghina L, Papa S. Oncogenic K-ras expression is associated with derangement of the cAMP/PKA pathway and forskolin-reversible alterations of mitochondrial dynamics and respiration. Oncogene 2013; 32:352-62; PMID:22410778
33. Hung LY, Tseng JT, Lee YC, Xia W, Wang YN, Wu ML, Chuang YH, Lai CH, Chang WC. Nuclear epidermal growth factor receptor (EGFR) interacts with signal transducer and activator of transcription 5 (STAT5) in activating Aurora-A gene expression. Nucleic Acids Res 2008; 36:4337-51; PMID:18586824; http://dx.doi.org/10.1093/nar/gkn417
34. Zunino R, Schauss A, Rippstein P, Andrade-Navarro M, McBride HM. The SUMO protease SENP5 is required to maintain mitochondrial morphology and function. J Cell Sci 2007; 120:1178-88; PMID:17341580; http://dx.doi.org/10.1242/jcs.03418
35. Liesa M, Borda-d'Agua B, Medina-Gómez G, Lelliott CJ, Paz JC, Rojo M, Palacín M, Vidal-Puig A, Zorzano A. Mitochondrial fusion is increased by the nuclear coactivator PGC-1beta. PLoS One 2008; 3:e3613; PMID:18974884; http://dx.doi.org/10.1371/journal.pone.0003613
36. Wieckowski MR, Giorgi C, Lebiedzinska M, Duszynski J, Pinton P. Isolation of mitochondria-associated membranes and mitochondria from animal tissues and cells. Nat Protoc 2009; 4:1582-90; PMID:19816421; http://dx.doi.org/10.1038/ nprot.2009.151
37. Park SJ, Park YJ, Shin JH, Kim ES, Hwang JJ, Jin DH, Kim JC, Cho DH. A receptor tyrosine kinase inhibitor, Tyrphostin A9 induces cancer cell death through Drp1 dependent mitochondria fragmentation. Biochem Biophys Res Commun 2011; 408:465-70; PMID:21527248; http://dx.doi.org/10.1016/j.bbrc.2011.04.053
38. Traxler P, Allegrini PR, Brandt R, Brueggen J, Cozens R, Fabbro D, Grosios K, Lane HA, McSheehy P, Mestan J, et al. AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity. Cancer Res 2004; 64:4931-41; PMID:15256466; http://dx.doi.org/10.1158/0008-5472.CAN-03- 3681
39. Karbowski M, Arnoult D, Chen H, Chan DC, Smith CL, Youle RJ. Quantitation of mitochondrial dynamics by photolabeling of individual organelles shows that mitochondrial fusion is blocked during the Bax activation phase of apoptosis. J Cell Biol 2004; 164:493-9; PMID:14769861; http://dx.doi.org/10.1083/jcb. 200309082
40. Ishihara N, Fujita Y, Oka T, Mihara K. Regulation of mitochondrial morphology through proteolytic cleavage of OPA1. EMBO J 2006; 25:2966-77; PMID:16778770; http://dx.doi.org/10.1038/sj.emboj.7601184
41. Ehses S, Raschke I, Mancuso G, Bernacchia A, Geimer S, Tondera D, Martinou JC, Westermann B, Rugarli EI, Langer T. Regulation of OPA1 processing and mitochondrial fusion by m-AAA protease isoenzymes and OMA1. J Cell Biol 2009; 187:1023-36; PMID:20038678; http://dx.doi.org/10.1083/jcb.200906084
42. Merkwirth C, Dargazanli S, Tatsuta T, Geimer S, Löwer B, Wunderlich FT, von Kleist-Retzow JC, Waisman A, Westermann B, Langer T. Prohibitins control cell proliferation and apoptosis by regulating OPA1-dependent cristae morphogenesis in mitochondria. Genes Dev 2008; 22:476-88; PMID:18281461; http://dx.doi.org/10.1101/gad.460708
43. Brown JL, Johnston JM. Radioassay of lipid components separated by thin-layer chromatography. J Lipid Res 1962; 11:480-1
44. Zaidi N, Swinnen JV, Smans K. ATP-citrate lyase: a key player in cancer metabolism. Cancer Res 2012; 72:3709-14; PMID:22787121; http://dx.doi.org/10. 1158/0008-5472.CAN-11-4112
45. Jones ML, Collins MO, Goulding D, Choudhary JS, Rayner JC. Analysis of protein palmitoylation reveals a pervasive role in Plasmodium development and pathogenesis. Cell Host Microbe 2012; 12:246-58; PMID:22901544; http://dx.doi.org/10.1016/j.chom.2012.06.005
46. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144:646-74; PMID:21376230; http://dx.doi.org/10.1016/j.cell.2011.02.013
47. Cantor JR, Sabatini DM. Cancer cell metabolism: one hallmark, many faces. Cancer Discov 2012; 2:881-98; PMID:23009760; http://dx.doi.org/10.1158/2159- 8290.CD-12-0345
48. Ding Y, Liu Z, Desai S, Zhao Y, Liu H, Pannell LK, Yi H, Wright ER, Owen LB, Dean-Colomb W, et al. Receptor tyrosine kinase ErbB2 translocates into mitochondria and regulates cellular metabolism. Nat Commun 2012; 3:1271; PMID:23232401; http://dx.doi.org/10.1038/ncomms2236
49. Mollner S, Ferreira P, Beck K, Pfeuffer T. Nonenzymatic palmitoylation at Cys 3 causes extra-activation of the alpha-subunit of the stimulatory GTP-binding protein Gs. Eur J Biochem 1998; 257:236-41; PMID:9799124; http://dx.doi.org/10.1046/j.1432-1327.1998.2570236.x
50. Resh MD. Palmitoylation of ligands, receptors, and intracellular signaling molecules. Sci STKE 2006; 2006:re14; PMID:17077383; http://dx.doi.org/10.1126/stke.3592006re14
51. Di Vizio D, Adam RM, Kim J, Kim R, Sotgia F, Williams T, Demichelis F, Solomon KR, Loda M, Rubin MA, et al. Caveolin-1 interacts with a lipid raft-associated population of fatty acid synthase. Cell Cycle 2008; 7:2257-67; PMID:18635971; http://dx.doi.org/10.4161/cc.7.14.6475
52. Weihua Z, Tsan R, Huang WC, Wu Q, Chiu CH, Fidler IJ, Hung MC. Survival of cancer cells is maintained by EGFR independent of its kinase activity. Cancer Cell 2008; 13:385-93; PMID:18455122; http://dx.doi.org/10.1016/j.ccr.2008.03. 015
53. Ren J, Bollu LR, Su F, Gao G, Xu L, Huang WC, Hung MC, Weihua Z. EGFR-SGLT1 interaction does not respond to EGFR modulators, but inhibition of SGLT1 sensitizes prostate cancer cells to EGFR tyrosine kinase inhibitors. Prostate 2013; 73:1453-61; PMID:23765757; http://dx.doi.org/10.1002/pros.22692
54. Cohen EE, Rosen F, Stadler WM, Recant W, Stenson K, Huo D, Vokes EE. Phase II trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neck. J Clin Oncol 2003; 21:1980-7; PMID:12743152; http://dx.doi.org/10.1200/JCO.2003.10.051
55. Dancey JE, Freidlin B. Targeting epidermal growth factor receptor - are we missing the mark? Lancet 2003; 362:62-4; PMID:12853203; http://dx.doi.org/10. 1016/S0140-6736(03)13810-X
56. Weiss J. First line erlotinib for NSCLC patients not selected by EGFR mutation: keep carrying the TORCH or time to let the flame die? Transl Lung Cancer Res 2012; 1:219-23
57. Arteaga CL. Overview of epidermal growth factor receptor biology and its role as a therapeutic target in human neoplasia. Semin Oncol 2002; 29(Suppl 14):3-9; PMID:12422308; http://dx.doi.org/10.1053/sonc.2002.35642
58. Arteaga CL. Epidermal growth factor receptor dependence in human tumors: more than just expression? Oncologist 2002; 7(Suppl 4):31-9; PMID:12202786; http://dx.doi.org/10.1634/theoncologist.7-suppl-4-31
59. Witkowski A, Ghosal A, Joshi AK, Witkowska HE, Asturias FJ, Smith S. Head-to-head coiled arrangement of the subunits of the animal fatty acid synthase. Chem Biol 2004; 11:1667-76; PMID:15610851; http://dx.doi.org/10.1016/ j.chembiol.2004.09.016
60. Mannella CA. Structure of the outer mitochondrial membrane: ordered arrays of porelike subunits in outer-membrane fractions from Neurospora crassa mitochondria. J Cell Biol 1982; 94:680-7; PMID:6215413; http://dx.doi.org/10. 1083/jcb.94.3.680